Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism - PubMed (original) (raw)
Review
Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism
N S Shachter. Curr Opin Lipidol. 2001 Jun.
Abstract
Apolipoprotein (apo)C-I and apoC-III are constituents of HDL and of triglyceride-rich lipoproteins that slow the clearance of triglyceride-rich lipoproteins by a variety of mechanisms. ApoC-I is an inhibitor of lipoprotein binding to the LDL receptor, LDL receptor-related protein, and VLDL receptor. It also is the major plasma inhibitor of cholesteryl ester transfer protein, and appears to interfere directly with fatty acid uptake. ApoC-III also interferes with lipoprotein particle clearance, but its principal role is as an inhibitor of lipolysis, both through the biochemical inhibition of lipoprotein lipase and by interfering with lipoprotein binding to the cell-surface glycosaminoglycan matrix where lipolytic enzymes and lipoprotein receptors reside. Variation in the expression of apoC-III has been credibly documented to have an important role in hypertriglyceridemia. Variation in the expression of apoC-I may also be important for hypertriglyceridemia under certain circumstances.
Similar articles
- Insights into apolipoprotein C metabolism from transgenic and gene-targeted mice.
Jong MC, Havekes LM. Jong MC, et al. Int J Tissue React. 2000;22(2-3):59-66. Int J Tissue React. 2000. PMID: 10937355 Review. - Inhibitory effects of specific apolipoprotein C-III isoforms on the binding of triglyceride-rich lipoproteins to the lipolysis-stimulated receptor.
Mann CJ, Troussard AA, Yen FT, Hannouche N, Najib J, Fruchart JC, Lotteau V, André P, Bihain BE. Mann CJ, et al. J Biol Chem. 1997 Dec 12;272(50):31348-54. doi: 10.1074/jbc.272.50.31348. J Biol Chem. 1997. PMID: 9395464 - Further characterization of the metabolic properties of triglyceride-rich lipoproteins from human and mouse apoC-III transgenic mice.
Aalto-Setälä K, Weinstock PH, Bisgaier CL, Wu L, Smith JD, Breslow JL. Aalto-Setälä K, et al. J Lipid Res. 1996 Aug;37(8):1802-11. J Lipid Res. 1996. PMID: 8864964 - Influence of lipoprotein lipase and hepatic lipase on the transformation of VLDL and HDL during lipolysis of VLDL.
Murdoch SJ, Breckenridge WC. Murdoch SJ, et al. Atherosclerosis. 1995 Dec;118(2):193-212. doi: 10.1016/0021-9150(95)05606-8. Atherosclerosis. 1995. PMID: 8770314 - [THE LIPOLYSIS IN PHYLOGENETICALLY EARLY LIPOPROTEINS OF LOW DENSITY AND MORE LATER LIPOPROTEINS OF VERY LOW DENSITY: FUNCTION AND DIAGNOSTIC VALUE OF APOE AND APOC-III].
Rozhkova TA, Titov VN, Amelyushkina VA, Kaba SI, Kukhartchuk VV. Rozhkova TA, et al. Klin Lab Diagn. 2015 Dec;60(12):4-14. Klin Lab Diagn. 2015. PMID: 27032246 Review. Russian.
Cited by
- Closing the gaps in patient management of dyslipidemia: stepping into cardiovascular precision diagnostics with apolipoprotein profiling.
Reijnders E, van der Laarse A, Ruhaak LR, Cobbaert CM. Reijnders E, et al. Clin Proteomics. 2024 Mar 1;21(1):19. doi: 10.1186/s12014-024-09465-w. Clin Proteomics. 2024. PMID: 38429638 Free PMC article. Review. - Association of apolipoproteins C-I and C-II truncations with coronary heart disease and progression of coronary artery calcium: Multi-Ethnic Study of Atherosclerosis.
Koska J, Hu Y, Furtado J, Billheimer D, Nedelkov D, Allison M, Budoff MJ, McClelland RL, Reaven P. Koska J, et al. Atherosclerosis. 2023 Sep;380:117214. doi: 10.1016/j.atherosclerosis.2023.117214. Epub 2023 Aug 7. Atherosclerosis. 2023. PMID: 37573768 Free PMC article. - Apolipoprotein C1 promotes tumor progression in gastric cancer.
Gu Q, Zhan T, Guan X, Lai C, Lu NA, Wang G, Xu L, Gao X, Zhang J. Gu Q, et al. Oncol Res. 2023 May 24;31(3):287-297. doi: 10.32604/or.2023.028124. eCollection 2023. Oncol Res. 2023. PMID: 37305389 Free PMC article. - Lipoprotein(a) induces caspase-1 activation and IL-1 signaling in human macrophages.
Lorey MB, Youssef A, Äikäs L, Borrelli M, Hermansson M, Assini JM, Kemppainen A, Ruhanen H, Ruuth M, Matikainen S, Kovanen PT, Käkelä R, Boffa MB, Koschinsky ML, Öörni K. Lorey MB, et al. Front Cardiovasc Med. 2023 May 24;10:1130162. doi: 10.3389/fcvm.2023.1130162. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37293282 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources